11d
The Manila Times on MSNParents decry dismissal of Dengvaxia casesA GROUP of parents whose children's deaths were linked to Dengvaxia vaccine said that the Department of Justice (DOJ) has ...
The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...
“We’re on the frontier of Pharma 4.0 — autonomous experimentation, advanced robotics, big data, smart factories, AI and machine learning,” said Karen Plaut, Purdue’s executive vice president for ...
CEOs of some of the largest drugmakers said this week they were encouraged after Trump said at a meeting with pharma executives late last year that these middlemen need to be eliminated.
As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...
For Fierce Pharma's day 1 news roundup, click here. Fierce Biotech's day 1 coverage can be found here. Below, check out the latest coverage from day 2, including a wrap-up of the scene outside of ...
The Impact of the US Biosecure Act on Global Pharma Manufacturing The US Biosecure Act has significant implications for the global pharmaceutical supply chain. By restricting Chinese companies ...
Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges.
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762. Shares were recently up more than 270% to $6. ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results